Ryan H Moy

12PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Radiation therapyMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 01, 2026
Advancing Gastric Cancer Chemoprevention: Early Signals and Ongoing Challenges.

|Jun 15, 2026
Rethinking the Siewert classification in the era of precision oncology.

|Jun 01, 2026
Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial.

|Dec 25, 2025
PKMYT1 inhibition induces DNA damage and synergizes with immune checkpoint blockade in CCNE1 -amplified gastroesophageal adenocarcinoma.

Sungjoo Jang, Lawrence W Wu, Jimyung Park

|Sep 15, 2025
Retrospective analysis of Claudin18.2 expression in ethnically diverse patients with gastroesophageal adenocarcinoma.

Sara Wallam, Jimyung Park, Lawrence W Wu

|Feb 13, 2025
The complex interplay of antibiotic use and immune checkpoint inhibition.

Lawrence W Wu, Ryan H Moy

Pageof 2

Frequent Collaborators

5 joint publications

Lawrence W Wu

3 joint publications

Jimyung Park

1 joint publications

Geoffrey Y Ku

1 joint publications

Henry S Walch